MEMBRANE PEPTIDE STRUCTURE VIA NMR & QUANTUM CHEMISTRY
通过 NMR 观察膜肽结构
基本信息
- 批准号:6281472
- 负责人:
- 金额:$ 2.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-01-15 至 1999-01-14
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The SIR provided L-[2- 13 C]Tryptophan; 2g
L-13- 13C]Tryptophan; 1.25g The idea behind this project is to make
13C-labeled gramicidins, as prototypical membrane penetrating
peptide/protein fragments, and to explore their structure using the
ISOTROPIC CARBON- 13 CHEMICAL SHIF'F, plus quantum chemistry, as a
probe of structure. Previous work has always focused on orientational
(15N, 2H, some 13C) information - the position of a line in an
oriented sample, rather than completely analyzing chemical shifts
using quantum chemistry, which is what we propose here. The ability
to analyze isotropic chemical shifts in proteins in structural terms
has a good chance of making may more systems amenable to
investigation, and Ca, Cb, Cg of Trp in gramicidin should be excellent
probes (especially since the Trps are functionally significant). By
combining the observed isotropic chemical shifts with the quantum
chemically computed shielding surfaces, one obtains for Trp the
solutions for c 1, c2 as well as f, y, c 1 results for Val, Leu. These
unique solutions remove problems associated with may dipolar or
quadrupolar derived geometry restraints, ans when combined with the
often more accurate (but multivalued) tensor data should yield very
accurate, unique NMR solutions, for f, y, c I, c2. Knowledge of Trp
orientations is important for understanding gramicidin action, and the
above results (together) with those we are planning to obtain with
commercially available 13C glycines and alanines) should together
clearly indicate the utility of chemical shifts in structure studies,
especially since the chemical shift is, in a sense, the most
fundamental NMR property.
SIR提供L-[2- 13 C]色氨酸;2 g
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric Oldfield其他文献
Eric Oldfield的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric Oldfield', 18)}}的其他基金
Next generation bisphosphonates for chemo- and immuno-therapy
用于化疗和免疫治疗的下一代双膦酸盐
- 批准号:
8444316 - 财政年份:2011
- 资助金额:
$ 2.13万 - 项目类别:
Next generation bisphosphonates for chemo- and immuno-therapy
用于化疗和免疫治疗的下一代双膦酸盐
- 批准号:
8627146 - 财政年份:2011
- 资助金额:
$ 2.13万 - 项目类别:
Next generation bisphosphonates for chemo- and immuno-therapy
用于化疗和免疫治疗的下一代双膦酸盐
- 批准号:
8825340 - 财政年份:2011
- 资助金额:
$ 2.13万 - 项目类别:
Next generation bisphosphonates for chemo- and immuno-therapy
用于化疗和免疫治疗的下一代双膦酸盐
- 批准号:
8085202 - 财政年份:2011
- 资助金额:
$ 2.13万 - 项目类别:
Prenyl Synthase Inhibitors: Novel Anti-Infective Agents
异戊二烯合酶抑制剂:新型抗感染剂
- 批准号:
7984564 - 财政年份:2002
- 资助金额:
$ 2.13万 - 项目类别:
Prenyldiphosphate Synthase Inhibitors: Novel Anti-Infective Agents
异戊二烯二磷酸合酶抑制剂:新型抗感染剂
- 批准号:
7686803 - 财政年份:2002
- 资助金额:
$ 2.13万 - 项目类别:
Prenyl Synthase Inhibitors: Novel Anti-Infective Agents
异戊二烯合酶抑制剂:新型抗感染剂
- 批准号:
8532682 - 财政年份:2002
- 资助金额:
$ 2.13万 - 项目类别:
相似海外基金
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
国家电子自旋共振光谱生物医学资源 (ACERT)
- 批准号:
10797623 - 财政年份:2022
- 资助金额:
$ 2.13万 - 项目类别:
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
国家电子自旋共振光谱生物医学资源 (ACERT)
- 批准号:
10653773 - 财政年份:2022
- 资助金额:
$ 2.13万 - 项目类别:
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
国家电子自旋共振光谱生物医学资源 (ACERT)
- 批准号:
10430665 - 财政年份:2022
- 资助金额:
$ 2.13万 - 项目类别:
The 1958 Birth Cohort Biomedical Resource - facilitating access to data and samples and enhancing future utility
1958 年出生队列生物医学资源 - 促进数据和样本的获取并增强未来的效用
- 批准号:
G1001799/2 - 财政年份:2013
- 资助金额:
$ 2.13万 - 项目类别:
Research Grant
The 1958 Birth Cohort Biomedical Resource - facilitating access to data and samples and enhancing future utility
1958 年出生队列生物医学资源 - 促进数据和样本的获取并增强未来的效用
- 批准号:
G1001799/1 - 财政年份:2011
- 资助金额:
$ 2.13万 - 项目类别:
Research Grant
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群
- 批准号:
7894014 - 财政年份:2009
- 资助金额:
$ 2.13万 - 项目类别: